Complement Therapeutics
UKEntry
2023
Hold
3yr
Status
Active
Who owns Complement Therapeutics?
Complement Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2023. Across its history, Complement Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
Panakes Partners SGRActive
2023 · present(3yr) · Panakes Fund Purple · 2021 · Life Sciences VC
GimvActive
present · Gimv Portfolio
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Complement Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Complement Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue